Related Experiment Video
Updated: May 24, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Tetraspanins stimulate protein synthesis in myeloma cell lines
Victoria Zismanov1, Liat Drucker, Oshrat Attar-Schneider
1Oncogenetic Laboratory, Meir Medical Center, Kfar Saba, Israel.
Abstract:
Intensive protein synthesis is a unique and differential trait of multiple myeloma (MM) cells. Previously we showed that tetraspanin (CD81, CD82) overexpression in MM cell lines attenuated Akt/mTOR cascades, activated UPR, and caused autophagic death, suggesting breach of protein homeostasis. Here, we explored the role of protein synthesis in the tetraspanin-induced MM cell death. Contrary to attenuation of the major metabolic regulator, mTOR we determined elevated steady-state levels of protein in CD81N1/CD82N1 transfected MM lines (RPMI-8226, CAG). Elevated levels of immunoglobulins supported increased protein production in RPMI-8226. Changes in cell morphology consistent with elevated protein synthesis were also determined (cell, nuclei, and nucleoli sizes and ratios). Increased levels of phospho-rpS6 and decreased levels of phospho-AMPK were consistent with increased translation but independent of mTOR. Involvement of p38 and its role in tetraspanin induced translation and cell death were demonstrated. Microarray analyses of tetraspanin transfected MM cell lines revealed activation of protein synthesis signaling cascades and signals implicated in ribosome biogenesis (snoRNAs). Finally, we showed tetraspanins elevated protein synthesis was instrumental to MM cells' death. This work explores and demonstrates that excessive protein translation can be detrimental to MM cell lines and therefore may present a therapeutic target. Proteostasis is particularly important in MM because it integrates the high levels of protein production unique to myeloma cells with critically important microenvironmental cues. We suggest that increasing translation may be the path of least resistance in MM and thus may afford a novel platform for strategically designed therapy.
Insights
Overexpressing tetraspanins in multiple myeloma (MM) cells increases protein synthesis, leading to cell death. This suggests targeting excessive protein translation could be a novel therapeutic strategy for MM.
Area of Science:
- Cancer Biology
- Cellular Metabolism
- Molecular Oncology
Background:
- Multiple myeloma (MM) cells exhibit intensive protein synthesis, a unique characteristic.
- Tetraspanin (CD81, CD82) overexpression in MM cell lines previously linked to UPR and autophagic death.
- Protein homeostasis is critical in MM due to high protein production and microenvironmental interactions.
Purpose of the Study:
- To investigate the role of protein synthesis in tetraspanin-induced multiple myeloma cell death.
- To explore the mechanisms by which tetraspanins influence protein translation and cell viability in MM.
- To identify potential therapeutic targets related to protein synthesis in multiple myeloma.
Main Methods:
- Transfection of MM cell lines (RPMI-8226, CAG) with CD81/CD82.
- Measurement of steady-state protein levels and immunoglobulin production.
- Analysis of cell morphology, phospho-rpS6, phospho-AMPK, and p38 involvement.
- Microarray analysis to identify activated signaling cascades and ribosome biogenesis pathways.
Main Results:
- Tetraspanin overexpression led to elevated protein synthesis, independent of mTOR attenuation.
- Increased phospho-rpS6 and decreased phospho-AMPK levels indicated enhanced translation.
- p38 activation was involved in tetraspanin-induced translation and cell death.
- Microarray data revealed activation of protein synthesis and ribosome biogenesis pathways.
Conclusions:
- Excessive protein translation, induced by tetraspanins, is detrimental to multiple myeloma cells.
- Targeting elevated protein synthesis represents a potential novel therapeutic strategy for MM.
- Manipulating protein translation could exploit a vulnerability in MM cells, offering a new therapeutic platform.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Drugs that Stabilize Microtubules

